Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus.
A tumour-associated antigen known as 90K has been found in high concentrations in the serum of patients infected with human immunodeficiency virus (HIV) even in the absence of neoplastic complications. In order to investigate the relationship between the production of 90K and soluble inflammatory mediators, we studied serum concentrations of the antigen, tumour necrosis factor-alpha (TNF-alpha), interleukin-I-alpha (IL-I-alpha), interferon-gamma (IFN-gamma), IFN-alpha, neopterin and beta 2-microglobulin (beta 2-m) in patients with non-neoplastic HIV infection at various stages of disease and in control persons. The antigen was detected in all those studied but its concentration was higher in HIV-infected patients compared with controls (P < 0.001), increasing progressively with advancing stages of disease. There was a negative correlation between concentrations of 90K and IL-I-alpha in patients in U.S.A. Centers for Disease Control groups II and III (P < 0.02) and also between that of 90K and both TNF-alpha (P < 0.01) and IL-I-alpha (P < 0.05) in control persons. The results indicate that 90K is not merely a tumour-associated antigen and that its production may be part of immune and inflammatory responses in the absence of neoplasia. The correlation between the concentrations of 90K and of some cytokines in asymptomatic patients and healthy persons suggests that 90K may be part of a network of immune and inflammatory reactants.
Senaldi
G
G
WHO-Immunology Research and Training Centre, Department of Pathology, University of Geneva, Basel, Switzerland.
Peakman
M
M
Natoli
C
C
Hussain
M J
MJ
Gallati
H
H
McManus
T
T
Vergani
D
D
Iacobelli
S
S
D000328:Adult; D000951:Antigens, Neoplasm / Q000097:blood*; D000957:Antigens, Viral, Tumor / Q000302:isolation & purification*; D014408:Biomarkers, Tumor; D001708:Biopterins / Q000031:analogs & derivatives / Q000097:blood; D002352:Carrier Proteins; D016207:Cytokines / Q000096:biosynthesis / Q000097:blood*; D005260:Female; D006023:Glycoproteins; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D016898:Interferon-alpha / Q000097:blood; D007371:Interferon-gamma / Q000097:blood; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000097:blood*; D019798:Neopterin; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D001613:beta 2-Microglobulin / Q000032:analysis; D016326:Extracellular Matrix Proteins
D000951:Antigens, Neoplasm; D000957:Antigens, Viral, Tumor; D014408:Biomarkers, Tumor; D001708:Biopterins; D002352:Carrier Proteins; D016207:Cytokines; D006023:Glycoproteins; D016898:Interferon-alpha; D007371:Interferon-gamma; D008074:Lipoproteins; D009363:Neoplasm Proteins; D019798:Neopterin; D014409:Tumor Necrosis Factor-alpha; D001613:beta 2-Microglobulin; C081856:LGALS3BP protein, human; D016326:Extracellular Matrix Proteins